Loading organizations...
Biotechnology company developing miRNA-based cancer therapeutics.
Curamir Therapeutics has raised $10.0M across 1 funding round.
Curamir Therapeutics has raised $10.0M in total across 1 funding round.
Curamir Therapeutics has raised $10.0M in total across 1 funding round.
Curamir Therapeutics's investors include Henry Chen.
Curamir Therapeutics has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in September 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 23, 2019 | $10.0M Series A | Henry Chen |